It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Compare volatility and returns in retirement index funds to strike a balance between potential growth and risk control for sustainable withdrawals.
24,638 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Regulators take center stage in crypto news as July regulation moves forward. Bitcoin and Ethereum hold steady amid p...
SK Hynix closed the largest foreign U.S. listing on record, raising $26.5 billion. Analysts question whether the 2026...
LAB token plummeted 97% as on-chain findings tied founder-funded wallets to multi-million-dollar sell-offs, prompting...
Ethereum hovers around $1,800 as thin volume and mixed social signals keep the market gridlocked. A tweet-driven mome...
A top tech analyst argues memory chips are the AI backbone, with a widening 15-to-1 demand-to-supply gap shaping mark...
When a top executive sells a large block of stock, investors want to know whether it signals trouble or simply person...
Compass has filed ethics complaints against Zillow across 26 states, highlighting disputes over how active listings a...
PayPal shares surged following unconfirmed reports of a joint takeover bid by Stripe and Advent International, valued...
Energy markets pivot as renewables rise and fossil fuels adapt; several penny stocks are drawing attention for their ...
Japan cleared a landmark crypto regime today, moving oversight under the Financial Instruments and Exchange Act and d...
Ethereum slid roughly 4% in the latest session, trading near $1,835. Analysts still see a path to $2,245 if macro and...